iHeart
Kyoto-shi
About iHeart
iHeart Japan Corporation is developing regenerative medicinal products for severe heart failure, using iPSC technologies. Its base technologies were invented by scientists of Kyoto University.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.3M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2016)
- Website: iheartjapan.jp
- Phone: [email protected]
Industries & Categories
Biotechnology, Consulting, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/iheart-15083 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.